bf/NASDAQ:EWTX_icon.png

COM:EDGEWISETX

Edgewise Therapeutics

  • Stock

Last Close

31.98

22/11 21:00

Market Cap

2.01B

Beta: -

Volume Today

352.86K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
1.73M
-
gross profit
-1.73M
-
selling and marketing expenses
-181K
-
general and administrative expenses
1.30M
-
2.21M
69.92%
11.03M
399.14%
5.47M
50.42%
23.45M
328.97%
selling general and administrative expenses
1.30M
-
2.21M
69.92%
11.03M
399.14%
5.47M
50.42%
23.27M
325.66%
research and development expenses
8.62M
-
14.98M
73.74%
32.19M
114.84%
16.61M
48.39%
89.35M
437.89%
other expenses
cost and expenses
9.92M
-
17.19M
73.24%
43.22M
151.37%
22.08M
48.91%
114.36M
417.94%
operating expenses
9.92M
-
17.19M
73.24%
43.22M
151.37%
22.08M
48.91%
112.63M
410.10%
interest expense
4.02M
-
ebitda
-9.80M
-
-17.01M
73.52%
-43.22M
154.10%
-22.08M
48.91%
-112.63M
410.10%
operating income
-9.92M
-
-17.19M
73.24%
-43.22M
151.37%
-22.08M
48.91%
-114.36M
417.94%
depreciation and amortization
123K
-
185K
50.41%
272K
47.03%
538K
97.79%
1.73M
221.93%
total other income expenses net
219K
-
69K
68.49%
402K
482.61%
2.66M
562.69%
14.19M
432.81%
income before tax
-9.71M
-
-17.12M
76.43%
-42.81M
150.03%
-19.41M
54.65%
-100.16M
415.91%
income tax expense
-219K
-
-69K
68.49%
-674K
876.81%
-4.02M
496.14%
net income
-9.49M
-
-17.05M
79.78%
-42.14M
147.09%
-15.40M
63.46%
-100.16M
550.54%
weighted average shs out
20.34M
-
46.57M
128.96%
37.53M
19.41%
53.59M
42.82%
63.72M
18.90%
weighted average shs out dil
20.34M
-
46.57M
128.96%
37.53M
19.41%
53.59M
42.82%
63.72M
18.90%
eps
-0.47
-
-0.37
21.28%
-1.12
202.70%
-0.29
74.11%
-1.57
441.38%
epsdiluted
-0.47
-
-0.37
21.28%
-1.12
202.70%
-0.29
74.11%
-1.57
441.38%

All numbers in (except ratios and percentages)